Navigation Links
Study charts origins of fear

A team of researchers led by the University of Toronto has charted how and where a painful event becomes permanently etched in the brain - a discovery that has implications for pain-related emotional disorders such as anxiety and post-traumatic stress.

U of T physiology professor Min Zhuo and his colleagues Professor Bong-Kiun Kaang of Seoul National University in South Korea, and Professor Bao-Ming Li of Fudan University in China have identified where emotional fear memory and pain begin by studying the biochemical processes in a different part of the brain. In a paper published in the Sept.15 issue of Neuron the researchers use mice to show how receptors activated in the pre-frontal cortex, the portion of the brain believed to be involved with higher intellectual functions, play a critical role in the development of fear. Previous research had pointed to activation in the hippocampus, an area buried in the forebrain that regulates emotion and memory, as the origin of fear memory.

"This is critical as it changes how and where scientists thought fear was developed," says Zhuo, the EJLB-CIHR Michael Smith Chair in Neurosciences and Mental Health. "By understanding the biomolecular mechanisms behind fear, we could potentially create therapeutic ways to ease emotional pain in people. Imagine reducing the ability of distressing events, such as amputations, to be permanently imprinted in the brain."

Zhuo says that fear memory does not occur immediately after a painful event; rather, it takes time for the memory to become part of our consciousness. The initial event activates NMDA receptors - molecules on cells that receive messages and then produce specific physiological effect in the cell - which are normally quiet but triggered when the brain receives a shock. Over time, the receptors leave their imprint on brain cells.

By delivering shocks to mice, the researchers activated the NMDA receptors and traced a subunit of the molecule - a protein called NR2B - long believed to be associated with fear memory in the hippocampus and the amygdala, an almond-shaped structure in front of the hippocampus. To further test the protein's influence, researchers reduced the amount in mice and found they were less hesitant to avoid shocks. "We tested the animals using both spatial and auditory cues," Zhuo says. "In one experiment, the mice received small shocks when entering a chamber and they developed fear memory. In another experiment, we used sound tones to be associated with shocks. When NR2B was blocked, they no longer avoided the chamber or reacted to the tone."

Zhuo and his team then studied the mice's brain slices and discovered traces of NR2B in the pre-frontal cortex, supporting their theory that fear memory develops in that region. "By identifying NR2B in the pre-frontal cortex of the brain, we propose that fear memory originates from a network of receptors, rather than one simple area," Zhuo says. "It is more complex than previously thought."

The next step, according to Zhuo, is to determine how NR2B directly affects memory formation and storage in the brain. "While we know it exists in the hippocampus, amygdala and the pre-frontal cortex, we don't know exactly how it alters them," Zhuo says. "Once we understand the implications for each part, we will be able to reduce levels of NR2B accordingly and effectively reduce fear memory. In the future, perhaps people can take therapeutic measures before experiencing a particularly discomforting situation." The University of Toronto Innovations Foundation is currently working with Zhuo to push for the translation of this finding into treatments.


'"/>

Source:University of Toronto


Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
3. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
4. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
5. Study Links Ebola Outbreaks To Animal Carcasses
6. Breakthrough Microarray-based Technology for the Study of Cancer
7. NYU Study Reveals How Brains Immune System Fights Viral Encephalitis
8. Study finds more than one-third of human genome regulated by RNA
9. Leukemia Drug Breakthrough Study In New England Journal Of Medicine
10. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
11. New Study from Affymetrix Laboratories Points to Changing View of How Genome Works
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/16/2016)... 2016 Sensory Inc ., a ... for consumer electronics, and VeriTran , a ... industry, today announced a global partnership that will ... authenticate users of mobile banking and mobile payments ... software which requires no specialized biometric scanners, yet ...
(Date:11/14/2016)... -- xG Technology, Inc. ("xG" or the "Company") (Nasdaq: XGTI, ... use in challenging operating environments, announced its results for ... hold a conference call to discuss these results on ... below). Key Recent Accomplishments ... to acquire Vislink Communication Systems. The purchase is expected ...
(Date:6/22/2016)... , June 22, 2016  The American College of ... Trade Show Executive Magazine as one of the fastest-growing ... May 25-27 at the Bellagio in Las Vegas ... the highest percentage of growth in each of the following ... exhibiting companies and number of attendees. The 2015 ACMG Annual ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... N.J. , Dec. 8, 2016  Soligenix, ... late-stage biopharmaceutical company focused on developing and commercializing ... an unmet medical need, announced today the long-term ... with SGX942 (dusquetide), a first-in-class Innate Defense Regulator ... in head and neck cancer patients undergoing chemoradiation ...
(Date:12/8/2016)... 2016  HedgePath Pharmaceuticals, Inc. (OTCQX: HPPI), a ... plans to commercialize innovative therapeutics for patients with ... were approved for trading on the OTCQX U.S. ... OTCQX, effective today, under the ticker symbol "HPPI." ... companies must meet high financial standards, follow best ...
(Date:12/8/2016)... Dec. 8, 2016 Eutilex Co. Ltd. today ... (US $18.9M) Series A financing. This financing round included ... Venture and SNU Bio Angel. This new funding brings ... KRW (US $27.7M) since its founding in 2015. ... the development and commercialization of its immuno-oncology programs, expand ...
(Date:12/8/2016)... SAN DIEGO , Dec. 8, 2016 /PRNewswire/ ... ), a leading commercial provider of clinically actionable ... cancer patients, announces that clinical data featuring its ... concordance to tissue biopsy for the detection of ... The results from research sponsored by Sara Cannon ...
Breaking Biology Technology: